Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer.

Cancers (Basel) · 2025 · PMC12110403 · PMID 40427227

Europe PMC DOI

hedged sentence

0.6000

closest p · 12.0× alpha

0.6000

boldest claim

The sentences

did not reach statistical significancep = 0.6not close (p > 0.1)

An increase in pSTAT3 levels was also seen in the enzalutamide monotherapy arm, but this did not reach statistical significance ( p = 0.6) ( Figure 5 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.